Zobrazeno 1 - 10
of 35
pro vyhledávání: ''
Autor:
Jean-Luc Raoul, Nathalie Charrier, Sandrine Oziel-Taieb, Gerard Cavaglione, Flora Poizat, L. Mineur, Gilles Piana, Christophe Zemmour, Patricia Niccoli
Publikováno v:
Anticancer Research
Anticancer Research, 2021, 41 (4), pp.2071-2078. ⟨10.21873/anticanres.14977⟩
Anticancer Research, 2021, 41 (4), pp.2071-2078. ⟨10.21873/anticanres.14977⟩
International audience; Background/Aim: FOLFOX (5-Fluorouracile and oxaliplatin) exhibits promising activity in advanced welldifferentiated neuroendocrine tumors (NETs). This retrospective study aimed to analyze the outcome of metastatic enteropancre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88af78f8fb872e2f7d049cd0ba32942d
https://www.hal.inserm.fr/inserm-03649596/file/2071.full.pdf
https://www.hal.inserm.fr/inserm-03649596/file/2071.full.pdf
Autor:
Stéphane Dalle, Patrick Combemale, Yannick Le Corre, Caroline Dutriaux, E. Varey, Nathalie Beneton, Thomas Jouary, Caroline Robert, Henri Montaudié, Jean Philippe Arnault, Sandrine Monestier, Marie Thérèse Leccia, Sandrine Mansard, Laurent Mortier, Amir Khammari, Anne-Bénédicte Duval Modeste, François Skowron, Nicolas Meyer, Brigitte Dréno, Nabahet Ameur, Bernard Guillot, Philippe Saiag, E. Hainaut, Sophie Dalac-Rat
Publikováno v:
International Journal of Cancer
International Journal of Cancer, Wiley, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩
International Journal of Cancer, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩
International Journal of Cancer, Wiley, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩
International Journal of Cancer, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩
International audience; This retrospective observational study aimed to determine the effectiveness, safety and patterns of the use of nivolumab in patients with advanced melanoma in real-world clinical practice in France using data from a Temporary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f417395eb026535a482cd67ec9bacb
https://hal.archives-ouvertes.fr/hal-03287366
https://hal.archives-ouvertes.fr/hal-03287366
Autor:
Esteban Brenet, Sylvain Morinière, Pierre Philouze, Jean Michel Goujon, Odile Casiraghi, Florent Espitalier, Laurence Digue, A. Auperin, Nicolas Fakhry, Christian Righini, Rabah Taouachi, Michel Wassef, Olivier Mauvais, Muriel Hourseau, Franck Jegoux, Bertrand Baujat, Marie Christine Kaminsky, Olivier Bouchain, Chloé Bertolus, Juliette Thariat, Jean Paul Marie, Valentin Calugaru, Emmanuelle Uro-Coste, Sarah Atallah, Anne Sudaka, Cécile Badoual, Nicolas Saroul, Philippe Schultz, Stéphanie Dakpé
Publikováno v:
European journal of cancer
European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩
European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩
International audience; Background: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head and neck tumours [1] and 10% of salivary glands malignant tumours. The main objective of our study is to investigate the prognostic factors influenci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172cb5681f91e2f434860e150f1ec6cd
https://hal-u-picardie.archives-ouvertes.fr/hal-03599053
https://hal-u-picardie.archives-ouvertes.fr/hal-03599053
Autor:
Valérie Gounant, Baptiste Abbar, Claire Danel, Sandra Assoun, Nathalie Théou-Anton, Marina Nguenang, Johan Pluvy, Aurélie Cazes, Antoine Khalil, Céline Namour, Gérard Zalcman, Solenn Brosseau
Publikováno v:
Lung Cancer
Lung Cancer, Elsevier, 2019, 132, pp.65-71. ⟨10.1016/j.lungcan.2019.04.005⟩
Lung Cancer, Elsevier, 2019, 132, pp.65-71. ⟨10.1016/j.lungcan.2019.04.005⟩
Introduction Tumor mutational burden (TMB) correlates with response to immune checkpoint inhibitors (ICI) in advanced non-small-cell lung cancer (aNSCLC). We hypothesized that TP53 mutations could reflect TMB and be associated with ICI benefit. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87b57ffc47fff47d3b28b188ab317d4
https://hal.archives-ouvertes.fr/hal-03477631/file/S0169500219303927.pdf
https://hal.archives-ouvertes.fr/hal-03477631/file/S0169500219303927.pdf
Autor:
Claire Falandry, Pauline Corbaux, Marie Perier-Muzet, Stéphane Dalle, Amélie Boespflug, Myriam Locatelli-Sanchez, Lize Kiakouama-Maleka, Julien Péron, Denis Maillet, Michaël Duruisseaux
Publikováno v:
Eur J Cancer
Eur J Cancer, 2019, 121, pp.192--201. ⟨10.1016/j.ejca.2019.08.027⟩
Eur J Cancer, 2019, 121, pp.192--201. ⟨10.1016/j.ejca.2019.08.027⟩
International audience; BACKGROUND: Age-related immune dysfunction might impair the efficacy of immune checkpoint inhibitors (ICIs) in older patients. We aimed to evaluate the impact of age on clinical outcomes and tolerance of ICIs in a real-life se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f8d3913d7d8f3cfc9f1e9902baac41
https://hal.science/hal-02465794/file/S0959804919304873.pdf
https://hal.science/hal-02465794/file/S0959804919304873.pdf
Autor:
Maël Heiblig, Stephane Morisset, Franck E. Nicolini, Lucila Sackmann-Sala, Viviane Dubruille, Philippe Rousselot, Lydia Roy, Shanti Ame, Delphine Rea, Gabriel Etienne, Marie-Lorraine Chretien, Françoise Huguet, Aude Charbonnier, Emilie Cayssials, Agnès Guerci-Bresler, Valérie Coiteux, Mohamad Sobh, Eric Hermet, Martine Escoffre-Barbe
Publikováno v:
Experimental Hematology
Experimental Hematology, Elsevier, 2018, 67, pp.41-48. ⟨10.1016/j.exphem.2018.08.006⟩
Experimental Hematology, Elsevier, 2018, 67, pp.41-48. ⟨10.1016/j.exphem.2018.08.006⟩
IF 2.436 (2017); International audience; Ponatinib represents a remarkable progress in the treatment of heavily pretreated chronic myelogenous leukemia (CML) and de novo Philadelphia chromosome-positive ALL patients despite significant toxicity in cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b97eed8cfbf897d906defddb0492461
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01927788
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01927788
Autor:
Elodie Collinge, Etienne Paubelle, Sophie Ducastelle, Gilles Salles, Hélène Labussière, Eric Wattel, Fiorenza Barraco, Marie-Virginie Larcher, Xavier Thomas, Maël Heiblig, Alexandre Deloire, Mohamed Elhamri, Sandrine Loron
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia
Clinical Lymphoma Myeloma and Leukemia, 2018, 18 (5), pp.e211-e218. 〈10.1016/j.clml.2018.02.018〉
Clinical Lymphoma Myeloma and Leukemia, 2018, 18 (5), pp.e211-e218. 〈10.1016/j.clml.2018.02.018〉
Introduction Secondary acute myeloid leukemia (sAML) remains a therapeutic challenge. In elderly patients with AML, it is unclear whether sAML displays an inferior outcome compared with de novo AML. Patients and Methods We studied AML with an anteced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733a83c6f242bd1ce23aa1f93f02b5e5
https://hal.archives-ouvertes.fr/hal-01815853
https://hal.archives-ouvertes.fr/hal-01815853
Autor:
François Chasset, Jean Capron, Francis Berenbaum, Sonia Alamowitch, Arsène Mekinian, Fabrice Carrat, Olivier Fain, Aurelia Retbi, Eric Rondeau, Olivier Chazouillères, Eric Grignano, Paul Coppo, Jean-Jacques Boffa, Jérémie Sellam, Pierre Ronco, Camille Francès, Vincent Jachiet
Publikováno v:
Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2018, 59 (6), pp.1399-1405. ⟨10.1080/10428194.2017.1379075⟩
Leukemia & lymphoma, Taylor & Francis, 2018, 59 (6), pp.1399-1405. ⟨10.1080/10428194.2017.1379075⟩
This French multicenter retrospective cohort study aimed to describe the autoimmune manifestations (AIMs) associated with lymphoma among patients hospitalized between 2005 and 2016 in three French University Hospitals. Among 2503 patients with lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe63d4e31d6862832a531bf0e82f48a
https://hal.archives-ouvertes.fr/hal-02381016
https://hal.archives-ouvertes.fr/hal-02381016
Autor:
Aurélie Maran-Gonzalez, Marian Gutowski, Pierre-Emmanuel Colombo, Marie Alexandre, William Jacot, Simon Thezenas, Marie Viala, Séverine Guiu, Gilles Romieu, Pierre-Jean Lamy
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2017, 165 (3), pp.611-621. ⟨10.1007/s10549-017-4373-7⟩
Breast Cancer Research and Treatment, Springer Verlag, 2017, 165 (3), pp.611-621. ⟨10.1007/s10549-017-4373-7⟩
International audience; PURPOSE:Intermediate-risk early breast cancer (EBC) is a heterogeneous group in which adjuvant chemotherapy decision proves to be difficult. Clinical and pathological criteria are sometimes insufficient to determine the best t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5aca09bbde8f675a5b80f21d4f1279d
https://hal.umontpellier.fr/hal-02430641
https://hal.umontpellier.fr/hal-02430641
Autor:
Valérie Taly, Julien Taieb, Géraldine Perkins, Frédéric Di Fiore, Hélène Blons, Fanny Garlan, Pierre Michel, Nathalie Siauve, Aziz Zaanan, Pierre Laurent-Puig, Claire Mulot, David Sefrioui, Nasrin Sarafan-Vasseur, Audrey Didelot
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (18), pp.5416-5425. ⟨10.1158/1078-0432.CCR-16-3155⟩
Clinical Cancer Research, American Association for Cancer Research, 2017, 23 (18), pp.5416-5425. ⟨10.1158/1078-0432.CCR-16-3155⟩
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are essential for optimization of treatment strategies. We evaluated the applicability of early changes in circulating tumor DNA (ctDNA) as a marker of therapeutic effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c045e33ce217f8ff427d348e52638bb
https://www.hal.inserm.fr/inserm-02299521/document
https://www.hal.inserm.fr/inserm-02299521/document